Mesalamine Market, Global Outlook and Forecast 2023-2029

Report ID: MMG51539 | Category: Pharma & Healthcare | Pages: 70 | Format: PDF | Published Date: February 21,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
This report aims to provide a comprehensive presentation of the global market for Mesalamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine. This report contains market size and forecasts of Mesalamine in global, including the following market information:
Global Mesalamine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Mesalamine Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Mesalamine companies in 2022 (%)
The global Mesalamine market was valued at US$ 161 million in 2022 and is projected to reach US$ 198.9 million by 2029, at a CAGR of 3.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mesalamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesalamine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Mesalamine Market Segment Percentages, by Type, 2022 (%)
    Purity ≥ 97%
    Purity ≥ 98%
    Purity ≥ 99%
Global Mesalamine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Mesalamine Market Segment Percentages, by Application, 2022 (%)
    Mesalazine Tablets
    Mesalazine Capsules
    Others
Global Mesalamine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Mesalamine Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mesalamine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Mesalamine revenues share in global market, 2022 (%)
Key companies Mesalamine sales in global market, 2018-2023 (Estimated), (MT)
Key companies Mesalamine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Syntese A/S
    Divis Laboratories
    Cambrex Corporation
    Ipca Laboratories
    Hangzhou Brother
    PharmaZell
    Lianyungang Fengheng Biopharm
    Lasa Loboratory
    Erregierre SpA
    Corden Pharma Bergamo
    CTX Lifescience
    Ishita Active Pharma Ingredients
    YC Biotech (Jiangsu)
    Xinxiang Tianfeng Fine Chemical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mesalamine, market overview.
Chapter 2: Global Mesalamine market size in revenue and volume.
Chapter 3: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesalamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Mesalamine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Mesalamine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Mesalamine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Mesalamine Overall Market Size
    2.1 Global Mesalamine Market Size: 2022 VS 2029
    2.2 Global Mesalamine Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Mesalamine Sales: 2018-2029
3 Company Landscape
    3.1 Top Mesalamine Players in Global Market
    3.2 Top Global Mesalamine Companies Ranked by Revenue
    3.3 Global Mesalamine Revenue by Companies
    3.4 Global Mesalamine Sales by Companies
    3.5 Global Mesalamine Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Mesalamine Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Mesalamine Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Mesalamine Players in Global Market
        3.8.1 List of Global Tier 1 Mesalamine Companies
        3.8.2 List of Global Tier 2 and Tier 3 Mesalamine Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Mesalamine Market Size Markets, 2022 & 2029
        4.1.2 Purity ≥ 97%
        4.1.3 Purity ≥ 98%
        4.1.4 Purity ≥ 99%
    4.2 By Type - Global Mesalamine Revenue & Forecasts
        4.2.1 By Type - Global Mesalamine Revenue, 2018-2023
        4.2.2 By Type - Global Mesalamine Revenue, 2024-2029
        4.2.3 By Type - Global Mesalamine Revenue Market Share, 2018-2029
    4.3 By Type - Global Mesalamine Sales & Forecasts
        4.3.1 By Type - Global Mesalamine Sales, 2018-2023
        4.3.2 By Type - Global Mesalamine Sales, 2024-2029
        4.3.3 By Type - Global Mesalamine Sales Market Share, 2018-2029
    4.4 By Type - Global Mesalamine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Mesalamine Market Size, 2022 & 2029
        5.1.2 Mesalazine Tablets
        5.1.3 Mesalazine Capsules
        5.1.4 Others
    5.2 By Application - Global Mesalamine Revenue & Forecasts
        5.2.1 By Application - Global Mesalamine Revenue, 2018-2023
        5.2.2 By Application - Global Mesalamine Revenue, 2024-2029
        5.2.3 By Application - Global Mesalamine Revenue Market Share, 2018-2029
    5.3 By Application - Global Mesalamine Sales & Forecasts
        5.3.1 By Application - Global Mesalamine Sales, 2018-2023
        5.3.2 By Application - Global Mesalamine Sales, 2024-2029
        5.3.3 By Application - Global Mesalamine Sales Market Share, 2018-2029
    5.4 By Application - Global Mesalamine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Mesalamine Market Size, 2022 & 2029
    6.2 By Region - Global Mesalamine Revenue & Forecasts
        6.2.1 By Region - Global Mesalamine Revenue, 2018-2023
        6.2.2 By Region - Global Mesalamine Revenue, 2024-2029
        6.2.3 By Region - Global Mesalamine Revenue Market Share, 2018-2029
    6.3 By Region - Global Mesalamine Sales & Forecasts
        6.3.1 By Region - Global Mesalamine Sales, 2018-2023
        6.3.2 By Region - Global Mesalamine Sales, 2024-2029
        6.3.3 By Region - Global Mesalamine Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Mesalamine Revenue, 2018-2029
        6.4.2 By Country - North America Mesalamine Sales, 2018-2029
        6.4.3 US Mesalamine Market Size, 2018-2029
        6.4.4 Canada Mesalamine Market Size, 2018-2029
        6.4.5 Mexico Mesalamine Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Mesalamine Revenue, 2018-2029
        6.5.2 By Country - Europe Mesalamine Sales, 2018-2029
        6.5.3 Germany Mesalamine Market Size, 2018-2029
        6.5.4 France Mesalamine Market Size, 2018-2029
        6.5.5 U.K. Mesalamine Market Size, 2018-2029
        6.5.6 Italy Mesalamine Market Size, 2018-2029
        6.5.7 Russia Mesalamine Market Size, 2018-2029
        6.5.8 Nordic Countries Mesalamine Market Size, 2018-2029
        6.5.9 Benelux Mesalamine Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Mesalamine Revenue, 2018-2029
        6.6.2 By Region - Asia Mesalamine Sales, 2018-2029
        6.6.3 China Mesalamine Market Size, 2018-2029
        6.6.4 Japan Mesalamine Market Size, 2018-2029
        6.6.5 South Korea Mesalamine Market Size, 2018-2029
        6.6.6 Southeast Asia Mesalamine Market Size, 2018-2029
        6.6.7 India Mesalamine Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Mesalamine Revenue, 2018-2029
        6.7.2 By Country - South America Mesalamine Sales, 2018-2029
        6.7.3 Brazil Mesalamine Market Size, 2018-2029
        6.7.4 Argentina Mesalamine Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Mesalamine Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Mesalamine Sales, 2018-2029
        6.8.3 Turkey Mesalamine Market Size, 2018-2029
        6.8.4 Israel Mesalamine Market Size, 2018-2029
        6.8.5 Saudi Arabia Mesalamine Market Size, 2018-2029
        6.8.6 UAE Mesalamine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Syntese A/S
        7.1.1 Syntese A/S Company Summary
        7.1.2 Syntese A/S Business Overview
        7.1.3 Syntese A/S Mesalamine Major Product Offerings
        7.1.4 Syntese A/S Mesalamine Sales and Revenue in Global (2018-2023)
        7.1.5 Syntese A/S Key News & Latest Developments
    7.2 Divis Laboratories
        7.2.1 Divis Laboratories Company Summary
        7.2.2 Divis Laboratories Business Overview
        7.2.3 Divis Laboratories Mesalamine Major Product Offerings
        7.2.4 Divis Laboratories Mesalamine Sales and Revenue in Global (2018-2023)
        7.2.5 Divis Laboratories Key News & Latest Developments
    7.3 Cambrex Corporation
        7.3.1 Cambrex Corporation Company Summary
        7.3.2 Cambrex Corporation Business Overview
        7.3.3 Cambrex Corporation Mesalamine Major Product Offerings
        7.3.4 Cambrex Corporation Mesalamine Sales and Revenue in Global (2018-2023)
        7.3.5 Cambrex Corporation Key News & Latest Developments
    7.4 Ipca Laboratories
        7.4.1 Ipca Laboratories Company Summary
        7.4.2 Ipca Laboratories Business Overview
        7.4.3 Ipca Laboratories Mesalamine Major Product Offerings
        7.4.4 Ipca Laboratories Mesalamine Sales and Revenue in Global (2018-2023)
        7.4.5 Ipca Laboratories Key News & Latest Developments
    7.5 Hangzhou Brother
        7.5.1 Hangzhou Brother Company Summary
        7.5.2 Hangzhou Brother Business Overview
        7.5.3 Hangzhou Brother Mesalamine Major Product Offerings
        7.5.4 Hangzhou Brother Mesalamine Sales and Revenue in Global (2018-2023)
        7.5.5 Hangzhou Brother Key News & Latest Developments
    7.6 PharmaZell
        7.6.1 PharmaZell Company Summary
        7.6.2 PharmaZell Business Overview
        7.6.3 PharmaZell Mesalamine Major Product Offerings
        7.6.4 PharmaZell Mesalamine Sales and Revenue in Global (2018-2023)
        7.6.5 PharmaZell Key News & Latest Developments
    7.7 Lianyungang Fengheng Biopharm
        7.7.1 Lianyungang Fengheng Biopharm Company Summary
        7.7.2 Lianyungang Fengheng Biopharm Business Overview
        7.7.3 Lianyungang Fengheng Biopharm Mesalamine Major Product Offerings
        7.7.4 Lianyungang Fengheng Biopharm Mesalamine Sales and Revenue in Global (2018-2023)
        7.7.5 Lianyungang Fengheng Biopharm Key News & Latest Developments
    7.8 Lasa Loboratory
        7.8.1 Lasa Loboratory Company Summary
        7.8.2 Lasa Loboratory Business Overview
        7.8.3 Lasa Loboratory Mesalamine Major Product Offerings
        7.8.4 Lasa Loboratory Mesalamine Sales and Revenue in Global (2018-2023)
        7.8.5 Lasa Loboratory Key News & Latest Developments
    7.9 Erregierre SpA
        7.9.1 Erregierre SpA Company Summary
        7.9.2 Erregierre SpA Business Overview
        7.9.3 Erregierre SpA Mesalamine Major Product Offerings
        7.9.4 Erregierre SpA Mesalamine Sales and Revenue in Global (2018-2023)
        7.9.5 Erregierre SpA Key News & Latest Developments
    7.10 Corden Pharma Bergamo
        7.10.1 Corden Pharma Bergamo Company Summary
        7.10.2 Corden Pharma Bergamo Business Overview
        7.10.3 Corden Pharma Bergamo Mesalamine Major Product Offerings
        7.10.4 Corden Pharma Bergamo Mesalamine Sales and Revenue in Global (2018-2023)
        7.10.5 Corden Pharma Bergamo Key News & Latest Developments
    7.11 CTX Lifescience
        7.11.1 CTX Lifescience Company Summary
        7.11.2 CTX Lifescience Mesalamine Business Overview
        7.11.3 CTX Lifescience Mesalamine Major Product Offerings
        7.11.4 CTX Lifescience Mesalamine Sales and Revenue in Global (2018-2023)
        7.11.5 CTX Lifescience Key News & Latest Developments
    7.12 Ishita Active Pharma Ingredients
        7.12.1 Ishita Active Pharma Ingredients Company Summary
        7.12.2 Ishita Active Pharma Ingredients Mesalamine Business Overview
        7.12.3 Ishita Active Pharma Ingredients Mesalamine Major Product Offerings
        7.12.4 Ishita Active Pharma Ingredients Mesalamine Sales and Revenue in Global (2018-2023)
        7.12.5 Ishita Active Pharma Ingredients Key News & Latest Developments
    7.13 YC Biotech (Jiangsu)
        7.13.1 YC Biotech (Jiangsu) Company Summary
        7.13.2 YC Biotech (Jiangsu) Mesalamine Business Overview
        7.13.3 YC Biotech (Jiangsu) Mesalamine Major Product Offerings
        7.13.4 YC Biotech (Jiangsu) Mesalamine Sales and Revenue in Global (2018-2023)
        7.13.5 YC Biotech (Jiangsu) Key News & Latest Developments
    7.14 Xinxiang Tianfeng Fine Chemical
        7.14.1 Xinxiang Tianfeng Fine Chemical Company Summary
        7.14.2 Xinxiang Tianfeng Fine Chemical Business Overview
        7.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Major Product Offerings
        7.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Sales and Revenue in Global (2018-2023)
        7.14.5 Xinxiang Tianfeng Fine Chemical Key News & Latest Developments
8 Global Mesalamine Production Capacity, Analysis
    8.1 Global Mesalamine Production Capacity, 2018-2029
    8.2 Mesalamine Production Capacity of Key Manufacturers in Global Market
    8.3 Global Mesalamine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Mesalamine Supply Chain Analysis
    10.1 Mesalamine Industry Value Chain
    10.2 Mesalamine Upstream Market
    10.3 Mesalamine Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Mesalamine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Mesalamine Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?